AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Clinical trial results of StreptAvax presented at international vaccine conference.(Brief Article)
2002 JUN 12 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that Shelly McNeil of Dalhousie University in Halifax presented phase I clinical trial results for StreptAvax at the Fifth Annual Conference on Vaccine Research. McNeil's presentation described the first study in humans of StreptAvax, ID Biomedical's multivalent recombinant vaccine developed to prevent group A streptococcus infections.
The National Foundation for Infectious Diseases (NFID), a sponsor of the conference, issued a press release highlighting the clinical trial results of StreptAvax. The StreptAvax presentation was chosen by NFID because it "represents cutting edge development in the field, and holds great promise for improving public health in the U.S. and abroad."
The purpose of this press release was to call attention to two selected presentations from the conference, which disclosed particularly important scientific information and findings.
...- ID Biomedical announces clinical trial of StreptAvax(TM) fully enrolled.
- Press release article from: PR Newswire September 24, 2001 700+ words
...24 /PRNewswire/ - ID Biomedical announced today that...TM). StreptAvax, ID Biomedical's vaccine for the...testing. The current clinical trial is evaluating the safety...vaccine in children. ID Biomedical expects to enroll children...
- ID Biomedical initiates Streptavax(TM) Clinical Trial.
- Press release article from: PR Newswire July 24, 2001 700+ words
...PRNewswire/ - ID Biomedical Corporation today...started a Phase I/II Clinical Trial of StreptAvax...clinical trials. The clinical trial will initially evaluate...this portion of the clinical trial, ID Biomedical expects children...
- ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral...
- Press release article from: PR Newswire March 30, 2005 700+ words
...Holler, M.D., ID Biomedical's Chief Executive Officer. ID Biomedical is also conducting a similar clinical trial of Fluviral in Canada...review mechanisms. ID Biomedical and CBER have outlined a clinical trial program that will...
- ID Biomedical Announces Positive Preliminary Results From Clinical Trial of...
- Press release article from: PR Newswire January 7, 1999 700+ words
...PRNewswire/ -- ID Biomedical Corporation (IDB...preliminary results of the clinical trial of its rapid culture...308 samples tested. ID Biomedical President, Dr. Tony...Dr. Robert Bryan, ID Biomedical's Vice President...
- ID Biomedical announces positive results from FluINsure(TM) clinical trial.
- Press release article from: PR Newswire April 2, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation announced...Company's Phase I Clinical Trial of FluINsure...with FluINsure, ID Biomedical's non- living...from the Phase I Clinical Trial will be presented by ID Biomedical's Chief Scientific...
- ID Biomedical announces positive results from StreptAvax(TM) clinical trial;...
- Press release article from: PR Newswire March 20, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation...s Phase I Clinical Trial of StreptAvax...presentation of these clinical trial results. Anthony...M.D., ID Biomedical's Chief Executive...toxicities. These clinical trial results v
- ID Biomedical Announces Positive Results from Phase II Clinical Trial of...
- Press release article from: PR Newswire August 10, 2004 700+ words
...expanded Phase II Clinical Trial. - Key supportive...TSX - "IDB" ID Biomedical announced today...subject in the clinical trial has developed...will be used by ID Biomedical to approach...of the human clinical trial data of StreptAvax...
- ID Biomedical announces positive results from Phase II clinical trial of...
- News wire article from: Asia Africa Intelligence Wire August 10, 2004 700+ words
...Press Release) ID Biomedical announced the completion...No subject in the clinical trial has developed antibodies...will be used by ID Biomedical to approach Health...of four proteins. ID Biomedical is a biotechnology...
- ID Biomedical announces strong nasal immune responses in FluINsure(TM) clinical...
- Press release article from: PR Newswire July 8, 2002 700+ words
...FirstCall/ - ID Biomedical Corporation...s Phase I Clinical Trial of FluINsure...Affairs for ID Biomedical, said, "With...Data from the clinical trial will be presented...profile. About ID Biomedical ID Biomedical...
- ID Biomedical announces the beginning of a US Phase I clinical trial for plague...
- News wire article from: Asia Africa Intelligence Wire January 10, 2005 700+ words
...NewsBase - Press Release) ID Biomedical Corp announced the beginning of a Phase I clinical trial for a recombinant injectable...headed by DVC LLC, with ID Biomedical serving as the manufacturing...development partner. ID Biomedical began its collaboration...
Source: HighBeam Research, Clinical trial results of StreptAvax presented at international...